LncRNA-Safe contributes to cardiac fibrosis through Safe-Sfrp2-HuR complex in mouse myocardial infarction

Rationale: As a hallmark of various heart diseases, cardiac fibrosis ultimately leads to end-stage heart failure. Anti-fibrosis is a potential therapeutic strategy for heart failure. Long noncoding RNAs (lncRNAs) have emerged as critical regulators of heart diseases that promise to serve as therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Kaili, Lei, Wei, Wu, Hongchun, Wu, Jie, Yang, Zhuangzhuang, Yan, Shiping, Lu, Xing-Ai, Li, Jingjing, Xia, Xue, Han, Xinglong, Deng, Wenbo, Zhong, Guisheng, Zhao, Zhen-Ao, Hu, Shijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831303/
https://www.ncbi.nlm.nih.gov/pubmed/31695768
http://dx.doi.org/10.7150/thno.33920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831303/
https://www.ncbi.nlm.nih.gov/pubmed/31695768
http://dx.doi.org/10.7150/thno.33920

Ejemplares similares